Structure-based identification of triazole-based PARP1 inhibitors: insights from docking and molecular dynamics simulations

The integrated in silico screening and molecular dynamics simulation approach successfully identified promising triazole derivatives as potential PARP1 inhibitors. These findings provide valuable insights for the rational design and optimization of novel anticancer agents targeting PARP1.